Investor alert: law offices of howard g. smith continues its investigation of anavex life sciences corp. (avxl) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith continues its investigation on behalf of anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl) on behalf of investors concerning the company's possible violations of federal securities laws. on february 1, 2022, before the market opened, anavex announced that a phase 3 trial of anavex2-73 (blarcamesine) for rett syndrome met primary and secondary endpoints. following the announcement, several people on social media i
AVXL Ratings Summary
AVXL Quant Ranking